Many individuals outside the pharma industry have a maniacal vision of our senior executives.

It will take some time before we begin to see top-line results from the 2010 US Census. However, it's a pretty safe prediction that the new census will show us that we are at or near the point where more than one out of every three of the more than 300 million Americans did not designate themselves as white.

On Feb. 28, more than 30 countries across the world observed Rare Disease Day.

For generations, success in pharma could be virtually guaranteed by the three Ms: Put your best minds on discovering new treatments, invest enough money in development and commercialization and support the resulting brands with enough marketing, and you were golden.

Innovations in healthcare seem to be popping up in new places all the time, including the Consumer Electronics Show (CES) in January.

It dawned on me at the New Year, that it was some 20 years ago that the Coalition for Healthcare Communication came into being.

A brand is more than just a symbol, slogan or trade name. It transcends logos and visual identities. Brands establish identity, provide differentiation and, most importantly, drive economic value.

As our nation continues to debate how the healthcare system should be fixed, little attention has been paid to the need to better incorporate multiculturalism in the provision of medical care.

Advocacy organizations serve as primary drivers of opinion and knowledge with patients, media and policy makers.

In the 1990s, brand-based DTC advertising was a big breakthrough innovation in pharmaceutical marketing.